Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.

Busbee BG, Ho AC, Brown DM, Heier JS, Suñer IJ, Li Z, Rubio RG, Lai P; HARBOR Study Group.

Ophthalmology. 2013 May;120(5):1046-56. doi: 10.1016/j.ophtha.2012.10.014. Epub 2013 Jan 23.

2.

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.

Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC; PKC-DRS and PKC-DRS2 Study Groups.

Retina. 2011 Nov;31(10):2084-94. doi: 10.1097/IAE.0b013e3182111669.

PMID:
21862954
3.

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG; BRAVO Investigators.

Ophthalmology. 2010 Jun;117(6):1102-1112.e1. doi: 10.1016/j.ophtha.2010.02.021. Epub 2010 Apr 15.

PMID:
20398941
4.

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY; CRUISE Investigators.

Ophthalmology. 2010 Jun;117(6):1124-1133.e1. doi: 10.1016/j.ophtha.2010.02.022. Epub 2010 Apr 9.

PMID:
20381871
5.

Diabetic retinopathy and angiogenesis.

Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP.

Curr Diabetes Rev. 2009 Feb;5(1):8-13. Review.

PMID:
19199892
6.

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group.

Ophthalmology. 2009 Jan;116(1):57-65.e5. doi: 10.1016/j.ophtha.2008.10.018.

PMID:
19118696
7.

Functional and anatomical outcomes for intravitreal bevacizumab treatment of choroidal neovascularization in a patient with angioid streaks.

Garcia RA, Jablon EP, Oria V, Rodriguez-Fontal M, Alfaro DV 3rd, Parikh NS.

Retin Cases Brief Rep. 2008 Spring;2(2):136-40. doi: 10.1097/ICB.0b013e31814cee22.

PMID:
25389825
8.

Intravitreal triamcinolone for the treatment of diabetic macular edema.

Gómez-Ulla F, Marticorena J, Alfaro DV 3rd, Fernández M, Méndez ER, Rothen M.

Curr Diabetes Rev. 2006 Feb;2(1):99-112. Review.

PMID:
18220620
9.

Anti-macular degeneration agents.

Rothen M, Jablon E, Monares G, Fontal MR, Alfaro DV 3rd.

Ophthalmol Clin North Am. 2005 Dec;18(4):561-7. Review.

PMID:
16314219
10.

Fishing-related ocular trauma.

Alfaro DV 3rd, Jablon EP, Rodriguez Fontal M, Villalba SJ, Morris RE, Grossman M, Roig-Melo E.

Am J Ophthalmol. 2005 Mar;139(3):488-92.

PMID:
15767058
11.

Progressive outer retinal necrosis syndrome: successful treatment with a new combination of antiviral drugs.

Roig-Melo EA, Macky TA, Heredia-Elizondo ML, Alfaro DV 3rd.

Eur J Ophthalmol. 2001 Apr-Jun;11(2):200-2.

PMID:
11456028
12.

Shatter resistance of spectacle lenses.

Vinger PF, Parver L, Alfaro DV 3rd, Woods T, Abrams BS.

JAMA. 1997 Jan 8;277(2):142-4.

PMID:
8990340
13.

Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem.

Alfaro DV 3rd, Hudson SJ, Kasowski EJ, Barton CP, Brucker AJ, Lopez JD, Beverly DT, King LP.

Retina. 1997;17(2):139-45.

PMID:
9143043
14.

Intravenous gentamicin and ceftazidime in penetrating ocular trauma: a swine model.

Schech JM, Alfaro DV 3rd, Laughlin RM, Sanford EG, Briggs J, Dalgetty M.

Retina. 1997;17(1):28-32.

PMID:
9051839
15.

Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem.

Alfaro DV 3rd, Hudson SJ, offele JJ, Bevin AA, Mines M, Laughlin RM, Schoderbek RJ.

Retina. 1996;16(4):317-23.

PMID:
8865392

Supplemental Content

Loading ...
Support Center